{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "23", "@timestamp": "2021-02-23T15:32:27.000027-05:00", "@year": "2021", "@month": "02"}, "ait:date-sort": {"@day": "10", "@year": "2012", "@month": "12"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"city-group": "Bangkok", "country": "Thailand", "@afid": "60199575", "@country": "tha", "organization": [{"$": "Faculty of Medicine"}, {"$": "Siriraj Hosptial"}, {"$": "Mahidol University"}], "affiliation-id": [{"@afid": "60199575"}, {"@afid": "60012718"}]}, "author": [{"ce:given-name": "Kulkanya", "preferred-name": {"ce:given-name": "Kulkanya", "ce:initials": "K.", "ce:surname": "Chokephaibulkit", "ce:indexed-name": "Chokephaibulkit K."}, "@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Chokephaibulkit", "@auid": "7003974471", "ce:indexed-name": "Chokephaibulkit K."}, {"ce:given-name": "Orasri", "preferred-name": {"ce:given-name": "Orasri", "ce:initials": "O.", "ce:surname": "Wittawatmongkol", "ce:indexed-name": "Wittawatmongkol O."}, "@seq": "3", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Wittawatmongkol", "@auid": "35756672200", "ce:indexed-name": "Wittawatmongkol O."}, {"ce:given-name": "Wanatpreeya", "preferred-name": {"ce:given-name": "Wanatpreeya", "ce:initials": "W.", "ce:surname": "Phongsamart", "ce:indexed-name": "Phongsamart W."}, "@seq": "5", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Phongsamart", "@auid": "8885235300", "ce:indexed-name": "Phongsamart W."}, {"ce:given-name": "Nirun", "preferred-name": {"ce:given-name": "Nirun", "ce:initials": "N.", "ce:surname": "Vanprapar", "ce:indexed-name": "Vanprapar N."}, "@seq": "8", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Vanprapar", "@auid": "6701697019", "ce:indexed-name": "Vanprapar N."}]}, {"affiliation": {"city-group": "Bangkok", "country": "Thailand", "@afid": "60031780", "@country": "tha", "organization": [{"$": "HIV Netherland Australia Thailand Research Collaboration (HIV-NAT)"}, {"$": "Thai Red Cross AIDS Research Centre"}], "affiliation-id": [{"@afid": "60031780"}, {"@afid": "60016965"}]}, "author": [{"ce:given-name": "Wasana", "preferred-name": {"ce:given-name": "Wasana", "ce:initials": "W.", "ce:surname": "Prasitsuebsai", "ce:indexed-name": "Prasitsuebsai W."}, "@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Prasitsuebsai", "@auid": "55416839500", "ce:indexed-name": "Prasitsuebsai W."}, {"ce:given-name": "Meena", "preferred-name": {"ce:given-name": "Meena", "ce:initials": "M.", "ce:surname": "Gorowara", "ce:indexed-name": "Gorowara M."}, "@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Gorowara", "@auid": "24472697100", "ce:indexed-name": "Gorowara M."}, {"ce:given-name": "Jiratchiya", "preferred-name": {"ce:given-name": "Jiratchiya", "ce:initials": "J.", "ce:surname": "Sophonphan", "ce:indexed-name": "Sophonphan J."}, "@seq": "6", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Sophonphan", "@auid": "55199829700", "ce:indexed-name": "Sophonphan J."}, {"ce:given-name": "Stephen J.", "preferred-name": {"ce:given-name": "Stephen J.", "ce:initials": "S.J.", "ce:surname": "Kerr", "ce:indexed-name": "Kerr S.J."}, "@seq": "7", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Kerr", "@auid": "7102711578", "ce:indexed-name": "Kerr S.J."}, {"ce:given-name": "Thanyawee", "preferred-name": {"ce:given-name": "Thanyawee", "ce:initials": "T.", "ce:surname": "Puthanakit", "ce:indexed-name": "Puthanakit T."}, "@seq": "9", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Puthanakit", "@auid": "8071686900", "ce:indexed-name": "Puthanakit T."}, {"ce:given-name": "Chayapa", "preferred-name": {"ce:given-name": "Chayapa", "ce:initials": "C.", "ce:surname": "Pasomsap", "ce:indexed-name": "Pasomsap C."}, "@seq": "10", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Pasomsap", "@auid": "55510679700", "ce:indexed-name": "Pasomsap C."}, {"ce:given-name": "Tulathip", "preferred-name": {"ce:given-name": "Tulathip", "ce:initials": "T.", "ce:surname": "Suwanlerk", "ce:indexed-name": "Suwanlerk T."}, "@seq": "11", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Suwanlerk", "@auid": "35304321800", "ce:indexed-name": "Suwanlerk T."}, {"ce:given-name": "Jintanat", "preferred-name": {"ce:given-name": "Jintanat", "ce:initials": "J.", "ce:surname": "Ananworanich", "ce:indexed-name": "Ananworanich J."}, "@seq": "14", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ananworanich", "@auid": "35228696200", "ce:indexed-name": "Ananworanich J."}]}, {"affiliation": {"city-group": "Sydney, NSW", "country": "Australia", "@afid": "60026655", "@country": "aus", "organization": [{"$": "Kirby Institute of Infection and Immunity in Society"}, {"$": "University of New South Wales"}], "affiliation-id": [{"@afid": "60026655"}, {"@afid": "60028333"}]}, "author": [{"ce:given-name": "Stephen J.", "preferred-name": {"ce:given-name": "Stephen J.", "ce:initials": "S.J.", "ce:surname": "Kerr", "ce:indexed-name": "Kerr S.J."}, "@seq": "7", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Kerr", "@auid": "7102711578", "ce:indexed-name": "Kerr S.J."}, {"ce:given-name": "Jintanat", "preferred-name": {"ce:given-name": "Jintanat", "ce:initials": "J.", "ce:surname": "Ananworanich", "ce:indexed-name": "Ananworanich J."}, "@seq": "14", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ananworanich", "@auid": "35228696200", "ce:indexed-name": "Ananworanich J."}]}, {"affiliation": {"city-group": "Bangkok", "country": "Thailand", "@afid": "60028190", "@country": "tha", "organization": [{"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "104425653"}, "@dptid": "104425653"}, "author": [{"ce:given-name": "Thanyawee", "preferred-name": {"ce:given-name": "Thanyawee", "ce:initials": "T.", "ce:surname": "Puthanakit", "ce:indexed-name": "Puthanakit T."}, "@seq": "9", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Puthanakit", "@auid": "8071686900", "ce:indexed-name": "Puthanakit T."}, {"ce:given-name": "Jintanat", "preferred-name": {"ce:given-name": "Jintanat", "ce:initials": "J.", "ce:surname": "Ananworanich", "ce:indexed-name": "Ananworanich J."}, "@seq": "14", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ananworanich", "@auid": "35228696200", "ce:indexed-name": "Ananworanich J."}]}, {"affiliation": {"city-group": "Titusville, NJ", "country": "United States", "@afid": "108302187", "@country": "usa", "organization": {"$": "Tibotec Inc."}, "affiliation-id": {"@afid": "108302187"}}, "author": [{"ce:given-name": "Vanitha", "preferred-name": {"ce:given-name": "Vanitha", "ce:initials": "V.", "ce:surname": "Sekar", "ce:indexed-name": "Sekar V."}, "@seq": "12", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Sekar", "@auid": "16029492500", "ce:indexed-name": "Sekar V."}]}, {"affiliation": {"city-group": "Nijmegen", "country": "Netherlands", "@afid": "60002573", "@country": "nld", "organization": {"$": "Radboud University Nijmegen Medical Center"}, "affiliation-id": {"@afid": "60002573"}}, "author": [{"ce:given-name": "David", "preferred-name": {"ce:given-name": "David", "ce:initials": "D.", "ce:surname": "Burger", "ce:indexed-name": "Burger D."}, "@seq": "13", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Burger", "@auid": "55540576000", "ce:indexed-name": "Burger D."}]}, {"affiliation": {"city-group": "Bangkok", "country": "Thailand", "@afid": "60031780", "@country": "tha", "organization": [{"$": "SEARCH"}, {"$": "Thai Red Cross AIDS Research Centre"}], "affiliation-id": {"@afid": "60031780"}}, "author": [{"ce:given-name": "Jintanat", "preferred-name": {"ce:given-name": "Jintanat", "ce:initials": "J.", "ce:surname": "Ananworanich", "ce:indexed-name": "Ananworanich J."}, "@seq": "14", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ananworanich", "@auid": "35228696200", "ce:indexed-name": "Ananworanich J."}]}], "citation-title": "Pharmacokinetics of darunavir/ritonavir in Asian HIV-1-infected children aged \u22657 years", "abstracts": "Background: The Asian population, in general, has higher antiretroviral concentrations than those who are not Asian, but there are limited pharmacokinetic data for darunavir/ritonavir in Asian children. Methods: Thai children aged \u22657 years and with body weight (BW)\u226520 kg who were on darunavir/ritonavir for \u22652 weeks underwent 12-h pharmacokinetics with blood sampling before and at 1, 2, 4, 6, 8, 10 and 12 h postdosing. Darunavir/ritonavir doses were 375/100 mg twice daily (BW 20 to <30 kg, n=12), 450/100 mg twice daily (BW 30 to <40 kg, n=2) or 600/100 mg twice daily (BW \u226540 kg, n=5). Ritonavir 100 mg soft gel capsules were used instead of solution. Results: Of the 19 children, 8 were female, median age was 13 years (range 7-16) and median BW was 29.4 kg. The median duration of darunavir/ritonavir treatment was 11 months. The geometric mean values for darunavir were 60.3 hxmg/l for the area under the concentration-time curve at 0-12 h (AUC0-12), 8.3 mg/l for the maximum concentration (C max) and 3.1 for the concentration prior to the next dose (C 12) with no differences between dosing groups. All had C12 above the protein binding adjusted 50% effective concentration (EC 50) of protease inhibitor-resistant virus (0.55 mg/l). The darunavir pharmacokinetic parameters were similar to those in non-Asian individuals from the DELPHI study, in which 13 of 20 with BW<40 kg used 50 or 60 mg ritonavir boosting. Conclusions: Thai children aged \u22657 years who were on standard darunavir dosing with 100 mg ritonavir boosting had adequate and comparable darunavir AUC0-12, Cmaxand C12 to non-Asian children who mainly used lower doses of ritonavir boosting. A ritonavir boosting dose of 100 mg can be used for children weighing \u226520 kg, particularly when lower dose formulations are unavailable or if intolerant to the solution. \u00a92012 International Medical Press.", "correspondence": {"affiliation": {"city-group": "Bangkok", "country": "Thailand", "@country": "tha", "organization": [{"$": "HIV Netherland Australia Thailand Research Collaboration (HIV-NAT)"}, {"$": "Thai Red Cross AIDS Research Centre"}]}, "person": {"ce:initials": "J.", "ce:surname": "Ananworanich", "ce:indexed-name": "Ananworanich J."}}, "citation-info": {"citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"codencode": "ANTHF", "sourcetitle-abbrev": "Antiviral Ther.", "website": {"ce:e-address": {"$": "http://www.intmedpress.com/serveFile.cfm?sUID=ab4fa76b-ee6e-4d11-a904-d999b7986a6d", "@type": "url"}}, "@country": "gbr", "issn": [{"$": "13596535", "@type": "print"}, {"$": "20402058", "@type": "electronic"}], "volisspag": {"voliss": {"@volume": "17", "@issue": "7"}, "pagerange": {"@first": "1263", "@last": "1269"}}, "@type": "j", "publicationyear": {"@first": "2012"}, "sourcetitle": "Antiviral Therapy", "@srcid": "21790", "publicationdate": {"year": "2012", "date-text": {"@xfab-added": "true", "$": "2012"}}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "7", "classification-description": "Pediatrics and Pediatric Surgery"}, {"classification-code": "4.4", "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology; TREATMENT"}, {"classification-code": "4.12.2", "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology; VIROLOGY; RNA viruses"}, {"classification-code": "38.30", "classification-description": "Adverse Reactions Titles; CHEMOTHERAPEUTIC DRUGS"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "30.6.5", "classification-description": "Clinical and Experimental Pharmacology; PHARMACOLOGICAL AGENTS; Antiinfective agents"}, {"classification-code": "30.3", "classification-description": "Clinical and Experimental Pharmacology; PHARMACOKINETICS"}]}, {"@type": "ASJC", "classification": [{"$": "3004"}, {"$": "2736"}, {"$": "2725"}]}, {"@type": "SUBJABBR", "classification": [{"$": "PHAR"}, {"$": "MEDI"}]}]}, "tradenamegroup": {"tradenames": {"trademanuitem": [{"tradename": "norvir"}, {"tradename": "prezista", "manufacturer": {"@country": "usa", "$": "Tibotec"}}], "@type": "TNM"}}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "206361-99-1", "chemical-name": "darunavir"}, {"cas-registry-number": "155213-67-5", "chemical-name": "ritonavir"}]}, {"@source": "nlm", "chemical": [{"cas-registry-number": "0", "chemical-name": "HIV Protease Inhibitors"}, {"cas-registry-number": "0", "chemical-name": "Ritonavir"}, {"cas-registry-number": "0", "chemical-name": "Sulfonamides"}, {"cas-registry-number": "0", "chemical-name": "darunavir"}]}]}, "manufacturergroup": {"manufacturers": {"@type": "MNF", "manufacturer": {"@country": "usa", "$": "Tibotec"}}}}}, "item-info": {"copyright": [{"$": "Copyright 2013 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, {"$": "MEDLINE\u00ae is the source for the MeSH terms of this document.", "@type": "Medline Descriptors"}], "dbcollection": [{"$": "EMBASE"}, {"$": "BSTEIN"}, {"$": "MEDL"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "10", "@year": "2012", "@month": "12"}}, "itemidlist": {"itemid": [{"$": "366191092", "@idtype": "PUI"}, {"$": "2012712713", "@idtype": "EMBASE"}, {"$": "2012163646", "@idtype": "BSTEIN"}, {"$": "22954687", "@idtype": "MEDL"}, {"$": "84870498215", "@idtype": "SCP"}, {"$": "84870498215", "@idtype": "SGR"}], "ce:doi": "10.3851/IMP2347"}}, "tail": {"bibliography": {"@refcount": "25", "reference": [{"ref-fulltext": "Mills AM, Nelson M, Jayaweera D, et al. Once-daily darunavir/ritonavir vs lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis. AIDS 2009; 23:1679-1688.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Once-daily darunavir/ritonavir vs lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-Week analysis"}, "refd-itemidlist": {"itemid": {"$": "69449092725", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "1679", "@last": "1688"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.M.", "@_fa": "true", "ce:surname": "Mills", "ce:indexed-name": "Mills A.M."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Nelson", "ce:indexed-name": "Nelson M."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Jayaweera", "ce:indexed-name": "Jayaweera D."}], "et-al": null}, "ref-sourcetitle": "AIDS"}}, {"ref-fulltext": "Madruga JV, Berger D, McMurchie M, et al. Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled Phase III trial. Lancet 2007; 370:49-58. (Pubitemid 47023100)", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: A randomised controlled phase III trial"}, "refd-itemidlist": {"itemid": {"$": "34347329093", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "370", "@issue": "9581"}, "pagerange": {"@first": "49", "@last": "58"}}, "ref-text": "DOI 10.1016/S0140-6736(07)61049-6, PII S0140673607610496", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.V.", "@_fa": "true", "ce:surname": "Madruga", "ce:indexed-name": "Madruga J.V."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Berger", "ce:indexed-name": "Berger D."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "McMurchie", "ce:indexed-name": "McMurchie M."}, {"@seq": "4", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Suter", "ce:indexed-name": "Suter F."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Banhegyi", "ce:indexed-name": "Banhegyi D."}, {"@seq": "6", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ruxrungtham", "ce:indexed-name": "Ruxrungtham K."}, {"@seq": "7", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Norris", "ce:indexed-name": "Norris D."}, {"@seq": "8", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Lefebvre", "ce:indexed-name": "Lefebvre E."}, {"@seq": "9", "ce:initials": "M.-P.", "@_fa": "true", "ce:surname": "De Bethune", "ce:indexed-name": "De Bethune M.-P."}, {"@seq": "10", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Tomaka", "ce:indexed-name": "Tomaka F."}, {"@seq": "11", "ce:initials": "M.", "@_fa": "true", "ce:surname": "De Pauw", "ce:indexed-name": "De Pauw M."}, {"@seq": "12", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Vangeneugden", "ce:indexed-name": "Vangeneugden T."}, {"@seq": "13", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Spinosa-Guzman", "ce:indexed-name": "Spinosa-Guzman S."}]}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Clotet B, Bellos N, Molina JM, et al. Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials. Lancet 2007; 369:1169-1178. (Pubitemid 46541620)", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: A pooled subgroup analysis of data from two randomised trials"}, "refd-itemidlist": {"itemid": {"$": "34047207229", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "369", "@issue": "9568"}, "pagerange": {"@first": "1169", "@last": "1178"}}, "ref-text": "DOI 10.1016/S0140-6736(07)60497-8, PII S0140673607604978", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Clotet", "ce:indexed-name": "Clotet B."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Bellos", "ce:indexed-name": "Bellos N."}, {"@seq": "3", "ce:initials": "J.-M.", "@_fa": "true", "ce:surname": "Molina", "ce:indexed-name": "Molina J.-M."}, {"@seq": "4", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Cooper", "ce:indexed-name": "Cooper D."}, {"@seq": "5", "ce:initials": "J.-C.", "@_fa": "true", "ce:surname": "Goffard", "ce:indexed-name": "Goffard J.-C."}, {"@seq": "6", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Lazzarin", "ce:indexed-name": "Lazzarin A."}, {"@seq": "7", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Wohrmann", "ce:indexed-name": "Wohrmann A."}, {"@seq": "8", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Katlama", "ce:indexed-name": "Katlama C."}, {"@seq": "9", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Wilkin", "ce:indexed-name": "Wilkin T."}, {"@seq": "10", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Haubrich", "ce:indexed-name": "Haubrich R."}, {"@seq": "11", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Cohen", "ce:indexed-name": "Cohen C."}, {"@seq": "12", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Farthing", "ce:indexed-name": "Farthing C."}, {"@seq": "13", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Jayaweera", "ce:indexed-name": "Jayaweera D."}, {"@seq": "14", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Markowitz", "ce:indexed-name": "Markowitz M."}, {"@seq": "15", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Ruane", "ce:indexed-name": "Ruane P."}, {"@seq": "16", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Spinosa-Guzman", "ce:indexed-name": "Spinosa-Guzman S."}, {"@seq": "17", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Lefebvre", "ce:indexed-name": "Lefebvre E."}]}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Blanche S, Bologna R, Cahn P, et al. Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents. AIDS 2009; 23:2005-2013.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents"}, "refd-itemidlist": {"itemid": {"$": "70349973590", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "2005", "@last": "2013"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Blanche", "ce:indexed-name": "Blanche S."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Bologna", "ce:indexed-name": "Bologna R."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Cahn", "ce:indexed-name": "Cahn P."}], "et-al": null}, "ref-sourcetitle": "AIDS"}}, {"ref-fulltext": "TREAT Asia Pediatric HIV Observational Database (TApHOD); International Epidemiologic Databases to Evaluate AIDS (IeDEA) Southern Africa Paediatric Group. A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. J Int AIDS Soc 2011; 14:7.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa"}, "refd-itemidlist": {"itemid": {"$": "79952756675", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "7"}}, "ref-text": "TREAT Asia Pediatric HIV Observational Database (TApHOD); International Epidemiologic Databases to Evaluate AIDS (IeDEA) Southern Africa Paediatric Group", "ref-sourcetitle": "J Int AIDS Soc"}}, {"ref-fulltext": "World Health Organization. Antiretroviral therapy for HIV infection in infants and children in resource-limited settings, towards universal access: recommendations for a public health approach: 2010 revision. (Updated 15 December 2010. Accessed 15 December 2010.) Available from http://www.who.int/ hiv/pub/paediatric/infants2010/en/index.html", "@id": "6", "ref-info": {"ref-website": {"websitename": "World Health Organization", "ce:e-address": {"$": "http://www.who.int/hiv/pub/paediatric/infants2010/en/index.html", "@type": "url"}}, "refd-itemidlist": {"itemid": {"$": "33747150207", "@idtype": "SGR"}}, "ref-text": "(Updated 15 December 2010. Accessed 15 December 2010.) Available from", "ref-sourcetitle": "Antiretroviral Therapy for HIV Infection in Infants and Children in Resource-limited Settings, Towards Universal Access: Recommendations for a Public Health Approach: 2010 Revision"}}, {"ref-fulltext": "Gupta RK, Gibb DM, Pillay D. Management of paediatric HIV-1 resistance. Curr Opin Infect Dis 2009; 22:256-263.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Management of paediatric HIV-1 resistance"}, "refd-itemidlist": {"itemid": {"$": "65549118631", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "22"}, "pagerange": {"@first": "256", "@last": "263"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.K.", "@_fa": "true", "ce:surname": "Gupta", "ce:indexed-name": "Gupta R.K."}, {"@seq": "2", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Gibb", "ce:indexed-name": "Gibb D.M."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Pillay", "ce:indexed-name": "Pillay D."}]}, "ref-sourcetitle": "Curr Opin Infect Dis"}}, {"ref-fulltext": "Puthanakit T, van der Lugt J, Bunupuradah T, et al. Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children. J Antimicrob Chemother 2009; 64:1080-1086.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children"}, "refd-itemidlist": {"itemid": {"$": "73949117004", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "64"}, "pagerange": {"@first": "1080", "@last": "1086"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Puthanakit", "ce:indexed-name": "Puthanakit T."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Van Der Lugt", "ce:indexed-name": "Van Der Lugt J."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Bunupuradah", "ce:indexed-name": "Bunupuradah T."}], "et-al": null}, "ref-sourcetitle": "J Antimicrob Chemother"}}, {"ref-fulltext": "Plipat N, Cressey TR, Vanprapar N, Chokephaibulkit K. Efficacy and plasma concentrations of indinavir when boosted with ritonavir in human immunodeficiency virus-infected Thai children. Pediatr Infect Dis J 2007; 26:86-88. (Pubitemid 46045762)", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Efficacy and plasma concentrations of indinavir when boosted with ritonavir in human immunodeficiency virus-infected Thai children"}, "refd-itemidlist": {"itemid": {"$": "33846004830", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "26", "@issue": "1"}, "pagerange": {"@first": "86", "@last": "88"}}, "ref-text": "DOI 10.1097/01.inf.0000247140.94669.1b, PII 0000645420070100000021", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Plipat", "ce:indexed-name": "Plipat N."}, {"@seq": "2", "ce:initials": "T.R.", "@_fa": "true", "ce:surname": "Cressey", "ce:indexed-name": "Cressey T.R."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Vanprapar", "ce:indexed-name": "Vanprapar N."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Chokephaibulkit", "ce:indexed-name": "Chokephaibulkit K."}]}, "ref-sourcetitle": "Pediatric Infectious Disease Journal"}}, {"ref-fulltext": "Ananworanich J, Kosalaraksa P, Hill A, et al. Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children. Pediatr Infect Dis J 2005; 24:874-879. (Pubitemid 41475921)", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children"}, "refd-itemidlist": {"itemid": {"$": "26944437399", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24", "@issue": "10"}, "pagerange": {"@first": "874", "@last": "879"}}, "ref-text": "DOI 10.1097/01.inf.0000180578.38584.da", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ananworanich", "ce:indexed-name": "Ananworanich J."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Kosalaraksa", "ce:indexed-name": "Kosalaraksa P."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Hill", "ce:indexed-name": "Hill A."}, {"@seq": "4", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Siangphoe", "ce:indexed-name": "Siangphoe U."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Bergshoeff", "ce:indexed-name": "Bergshoeff A."}, {"@seq": "6", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Pancharoen", "ce:indexed-name": "Pancharoen C."}, {"@seq": "7", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Engchanil", "ce:indexed-name": "Engchanil C."}, {"@seq": "8", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ruxrungtham", "ce:indexed-name": "Ruxrungtham K."}, {"@seq": "9", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Burger", "ce:indexed-name": "Burger D."}]}, "ref-sourcetitle": "Pediatric Infectious Disease Journal"}}, {"ref-fulltext": "Gorowara M, Burger D, Hill A, Ruxrungtham K. Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries. Curr Opin HIV AIDS 2010; 5:90-96.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries"}, "refd-itemidlist": {"itemid": {"$": "74349123323", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "5"}, "pagerange": {"@first": "90", "@last": "96"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Gorowara", "ce:indexed-name": "Gorowara M."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Burger", "ce:indexed-name": "Burger D."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Hill", "ce:indexed-name": "Hill A."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ruxrungtham", "ce:indexed-name": "Ruxrungtham K."}]}, "ref-sourcetitle": "Curr Opin HIV AIDS"}}, {"ref-fulltext": "Ramautarsing R, Ananworanich J. Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings. AIDS Res Ther 2010; 7:18.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Generic and low dose antiretroviral therapy in adults and children: Implication for scaling up treatment in resource limited settings"}, "refd-itemidlist": {"itemid": {"$": "77953719289", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "18"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Ramautarsing", "ce:indexed-name": "Ramautarsing R."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ananworanich", "ce:indexed-name": "Ananworanich J."}]}, "ref-sourcetitle": "AIDS Res Ther"}}, {"ref-fulltext": "Prezista (darunavir). Prescribing Information. Tibotec Inc., Titusville, NJ, USA. (Updated December 2011. Accessed 15 December 2011.) Available from http://www.prezista.com/sites/default/files/pdf/us-package-insert.pdf", "@id": "13", "ref-info": {"ref-website": {"ce:e-address": {"$": "http://www.prezista.com/sites/default/files/pdf/us_package_insert.pdf", "@type": "url"}}, "ref-title": {"ref-titletext": "Prezista (darunavir)"}, "refd-itemidlist": {"itemid": {"$": "84870571242", "@idtype": "SGR"}}, "ref-text": "Tibotec Inc., Titusville, NJ, USA. (Updated December 2011. Accessed 15 December 2011.) Available from", "ref-sourcetitle": "Prescribing Information"}}, {"ref-fulltext": "Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. (Updated 10 January 2011. Accessed 22 November 2011.) Available from http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf.", "@id": "14", "ref-info": {"ref-website": {"ce:e-address": {"$": "http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf", "@type": "url"}}, "refd-itemidlist": {"itemid": {"$": "84855616052", "@idtype": "SGR"}}, "ref-text": "Panel on Antiretroviral Guidelines for Adults and Adolescents. Department of Health and Human Services. (Updated 10 January 2011. Accessed 22 November 2011.) Available from", "ref-sourcetitle": "Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents"}}, {"ref-fulltext": "Droste JA, Verweij-Van Wissen CP, Burger DM. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography. Ther Drug Monit 2003; 25:393-399. (Pubitemid 36638188)", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography"}, "refd-itemidlist": {"itemid": {"$": "0038103469", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "25", "@issue": "3"}, "pagerange": {"@first": "393", "@last": "399"}}, "ref-text": "DOI 10.1097/00007691-200306000-00023", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.A.H.", "@_fa": "true", "ce:surname": "Droste", "ce:indexed-name": "Droste J.A.H."}, {"@seq": "2", "ce:initials": "W.C.P.W.G.M.", "@_fa": "true", "ce:surname": "Verweij-van", "ce:indexed-name": "Verweij-van W.C.P.W.G.M."}, {"@seq": "3", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Burger", "ce:indexed-name": "Burger D.M."}]}, "ref-sourcetitle": "Therapeutic Drug Monitoring"}}, {"ref-fulltext": "Burger D, Teulen M, Eerland J, et al. The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program. Ther Drug Monit 2011; 33:239-243.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: A global proficiency testing program"}, "refd-itemidlist": {"itemid": {"$": "79953216672", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "33"}, "pagerange": {"@first": "239", "@last": "243"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Burger", "ce:indexed-name": "Burger D."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Teulen", "ce:indexed-name": "Teulen M."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Eerland", "ce:indexed-name": "Eerland J."}], "et-al": null}, "ref-sourcetitle": "Ther Drug Monit"}}, {"ref-fulltext": "Botton J, Heude B, Kettaneh A, et al. Cardiovascular risk factor levels and their relationships with overweight and fat distribution in children: the Fleurbaix Laventie Ville Sante II study. Metabolism 2007; 56:614-622. (Pubitemid 46591894)", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Cardiovascular risk factor levels and their relationships with overweight and fat distribution in children: The Fleurbaix Laventie Ville Sant\u00e9 II study"}, "refd-itemidlist": {"itemid": {"$": "34247123653", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "56", "@issue": "5"}, "pagerange": {"@first": "614", "@last": "622"}}, "ref-text": "DOI 10.1016/j.metabol.2006.12.006, PII S0026049507000224", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Botton", "ce:indexed-name": "Botton J."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Heude", "ce:indexed-name": "Heude B."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Kettaneh", "ce:indexed-name": "Kettaneh A."}, {"@seq": "4", "ce:initials": "J.-M.", "@_fa": "true", "ce:surname": "Borys", "ce:indexed-name": "Borys J.-M."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Lommez", "ce:indexed-name": "Lommez A."}, {"@seq": "6", "ce:initials": "J.-L.", "@_fa": "true", "ce:surname": "Bresson", "ce:indexed-name": "Bresson J.-L."}, {"@seq": "7", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Ducimetiere", "ce:indexed-name": "Ducimetiere P."}, {"@seq": "8", "ce:initials": "M.-A.", "@_fa": "true", "ce:surname": "Charles", "ce:indexed-name": "Charles M.-A."}]}, "ref-sourcetitle": "Metabolism: Clinical and Experimental"}}, {"ref-fulltext": "Sekar V, Van De Casteele T, Van Baelen B, et al. Dose selection and pharmacokinetics-pharmacodynamics of darunavir coadministered with low-dose ritonavir in the DELPHI (TMC114-C212) trial in treatment experienced, HIV-1-infected children and adolescents. 17th International AIDS Conference. 3-8 August 2008, Mexico City, Mexico, USA. Abstract TUPE0078.", "@id": "18", "ref-info": {"ref-title": {"ref-titletext": "Dose selection and pharmacokinetics-pharmacodynamics of darunavir coadministered with low-dose ritonavir in the DELPHI (TMC114-C212) trial in treatment experienced, HIV-1-infected children and adolescents"}, "refd-itemidlist": {"itemid": {"$": "84870556630", "@idtype": "SGR"}}, "ref-text": "Abstract TUPE0078", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Sekar", "ce:indexed-name": "Sekar V."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Van De Casteele", "ce:indexed-name": "Van De Casteele T."}, {"@seq": "3", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Van Baelen", "ce:indexed-name": "Van Baelen B."}], "et-al": null}, "ref-sourcetitle": "17th International AIDS Conference. 3-8 August 2008, Mexico City, Mexico, USA"}}, {"ref-fulltext": "King JR, Yogev R, Jean-Philippe P, et al. Steady-state pharmacokinetics of tenofovir based regimens in HIV-infected pediatric patients. Antimicrob Agents Chemother 2011; 55:4290-4294.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Steady-state pharmacokinetics of tenofovir based regimens in HIV-infected pediatric patients"}, "refd-itemidlist": {"itemid": {"$": "80051813706", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "55"}, "pagerange": {"@first": "4290", "@last": "4294"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.R.", "@_fa": "true", "ce:surname": "King", "ce:indexed-name": "King J.R."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Yogev", "ce:indexed-name": "Yogev R."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Jean-Philippe", "ce:indexed-name": "Jean-Philippe P."}], "et-al": null}, "ref-sourcetitle": "Antimicrob Agents Chemother"}}, {"ref-fulltext": "Sekar V, Vanden Abeele C, Van Baelen B, et al. Effect of extrinsic and intrinsic factors on the pharmacokinetics of darunavir/ritonavir in HIV-1-infected patients: results of a randomized, controlled, Phase III study (ARTEMIS). 9th International Workshop on Clinical Pharmacology of HIV Therapy. 7-9 April 2008, New Orleans, USA. Abstract P185.", "@id": "20", "ref-info": {"ref-title": {"ref-titletext": "Effect of extrinsic and intrinsic factors on the pharmacokinetics of darunavir/ritonavir in HIV-1-infected patients: Results of a randomized, controlled, Phase III study (ARTEMIS)"}, "refd-itemidlist": {"itemid": {"$": "84870516163", "@idtype": "SGR"}}, "ref-text": "Abstract P185", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Sekar", "ce:indexed-name": "Sekar V."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Vanden Abeele", "ce:indexed-name": "Vanden Abeele C."}, {"@seq": "3", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Van Baelen", "ce:indexed-name": "Van Baelen B."}], "et-al": null}, "ref-sourcetitle": "9th International Workshop on Clinical Pharmacology of HIV Therapy. 7-9 April 2008, New Orleans, USA"}}, {"ref-fulltext": "Hill A, van der Lugt J, Sawyer W, Boffito M. How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials. AIDS 2009; 23:2237-2245.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials"}, "refd-itemidlist": {"itemid": {"$": "70449440262", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "2237", "@last": "2245"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Hill", "ce:indexed-name": "Hill A."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Van Der Lugt", "ce:indexed-name": "Van Der Lugt J."}, {"@seq": "3", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Sawyer", "ce:indexed-name": "Sawyer W."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Boffito", "ce:indexed-name": "Boffito M."}]}, "ref-sourcetitle": "AIDS"}}, {"ref-fulltext": "Avihingsanon A, Gorowara M, Wongsabut J, et al. Pharmacokinetics of reduced dose darunavir/ritonavir. 12th International Workshop on Clinical Pharmacology of HIV Therapy. 13-15 April 2011, Miami, FL, USA. Poster P33.", "@id": "22", "ref-info": {"refd-itemidlist": {"itemid": {"$": "84870553321", "@idtype": "SGR"}}, "ref-text": "Pharmacokinetics of reduced dose darunavir/ritonavir. Poster P33", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon A."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Gorowara", "ce:indexed-name": "Gorowara M."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Wongsabut", "ce:indexed-name": "Wongsabut J."}], "et-al": null}, "ref-sourcetitle": "12th International Workshop on Clinical Pharmacology of HIV Therapy. 13-15 April 2011, Miami, FL, USA"}}, {"ref-fulltext": "Working Group on Antiretroviral Therapy and Medical Management of HIV-infected children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, August 16, 2010. US Department of Health and Human Services. (Updated 11 August 2011. Accessed 15 December 2010). Available from http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/pediatricguidelines.pdf", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-website": {"ce:e-address": {"$": "http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/ pediatricguidelines.pdf", "@type": "url"}}, "ref-title": {"ref-titletext": "Working Group on Antiretroviral Therapy and Medical Management of HIV-infected children"}, "refd-itemidlist": {"itemid": {"$": "84870569773", "@idtype": "SGR"}}, "ref-text": "August 16, US Department of Health and Human Services. (Updated 11 August 2011. Accessed 15 December 2010). Available from", "ref-sourcetitle": "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection"}}, {"ref-fulltext": "Briz V, Palladino C, Navarro M, et al. Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients. HIV Med 2011; 12:442-446.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients"}, "refd-itemidlist": {"itemid": {"$": "79959975874", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "442", "@last": "446"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Briz", "ce:indexed-name": "Briz V."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Palladino", "ce:indexed-name": "Palladino C."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Navarro", "ce:indexed-name": "Navarro M."}], "et-al": null}, "ref-sourcetitle": "HIV Med"}}, {"ref-fulltext": "Davies MA, Moultrie H, Eley B, et al. Virologic failure and second-line antiretroviral therapy in children in South Africa - the IeDEA Southern Africa collaboration. J Acquir Immune Defic Syndr 2011; 56:270-278.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Virologic failure and second-line antiretroviral therapy in children in South Africa - The IeDEA Southern Africa collaboration"}, "refd-itemidlist": {"itemid": {"$": "79951814365", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "56"}, "pagerange": {"@first": "270", "@last": "278"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Davies", "ce:indexed-name": "Davies M.A."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Moultrie", "ce:indexed-name": "Moultrie H."}, {"@seq": "3", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Eley", "ce:indexed-name": "Eley B."}], "et-al": null}, "ref-sourcetitle": "J Acquir Immune Defic Syndr"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60031780", "affilname": "Thai Red Cross Agency", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60199575", "affilname": "Siriraj Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Kensington", "@id": "60026655", "affilname": "The Kirby Institute", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655", "affiliation-country": "Australia"}, {"affiliation-city": "Nijmegen", "@id": "60002573", "affilname": "Radboud University Medical Center", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002573", "affiliation-country": "Netherlands"}, {"affiliation-city": "Titusville", "@id": "108302187", "affilname": "Tibotec Inc.", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/108302187", "affiliation-country": "United States"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84870498215", "dc:description": "Background: The Asian population, in general, has higher antiretroviral concentrations than those who are not Asian, but there are limited pharmacokinetic data for darunavir/ritonavir in Asian children. Methods: Thai children aged \u22657 years and with body weight (BW)\u226520 kg who were on darunavir/ritonavir for \u22652 weeks underwent 12-h pharmacokinetics with blood sampling before and at 1, 2, 4, 6, 8, 10 and 12 h postdosing. Darunavir/ritonavir doses were 375/100 mg twice daily (BW 20 to <30 kg, n=12), 450/100 mg twice daily (BW 30 to <40 kg, n=2) or 600/100 mg twice daily (BW \u226540 kg, n=5). Ritonavir 100 mg soft gel capsules were used instead of solution. Results: Of the 19 children, 8 were female, median age was 13 years (range 7-16) and median BW was 29.4 kg. The median duration of darunavir/ritonavir treatment was 11 months. The geometric mean values for darunavir were 60.3 hxmg/l for the area under the concentration-time curve at 0-12 h (AUC0-12), 8.3 mg/l for the maximum concentration (C max) and 3.1 for the concentration prior to the next dose (C 12) with no differences between dosing groups. All had C12 above the protein binding adjusted 50% effective concentration (EC 50) of protease inhibitor-resistant virus (0.55 mg/l). The darunavir pharmacokinetic parameters were similar to those in non-Asian individuals from the DELPHI study, in which 13 of 20 with BW<40 kg used 50 or 60 mg ritonavir boosting. Conclusions: Thai children aged \u22657 years who were on standard darunavir dosing with 100 mg ritonavir boosting had adequate and comparable darunavir AUC0-12, Cmaxand C12 to non-Asian children who mainly used lower doses of ritonavir boosting. A ritonavir boosting dose of 100 mg can be used for children weighing \u226520 kg, particularly when lower dose formulations are unavailable or if intolerant to the solution. \u00a92012 International Medical Press.", "pubmed-id": "22954687", "prism:coverDate": "2012-12-10", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84870498215", "dc:creator": {"author": [{"ce:given-name": "Kulkanya", "preferred-name": {"ce:given-name": "Kulkanya", "ce:initials": "K.", "ce:surname": "Chokephaibulkit", "ce:indexed-name": "Chokephaibulkit K."}, "@seq": "1", "ce:initials": "K.", "@_fa": "true", "affiliation": {"@id": "60199575", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"}, "ce:surname": "Chokephaibulkit", "@auid": "7003974471", "author-url": "https://api.elsevier.com/content/author/author_id/7003974471", "ce:indexed-name": "Chokephaibulkit K."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84870498215"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84870498215&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84870498215&origin=inward"}], "source-id": "21790", "citedby-count": "1", "prism:volume": "17", "subtype": "ar", "dc:title": "Pharmacokinetics of darunavir/ritonavir in Asian HIV-1-infected children aged \u22657 years", "openaccess": "0", "prism:issn": "13596535 20402058", "prism:issueIdentifier": "7", "subtypeDescription": "Article", "prism:publicationName": "Antiviral Therapy", "prism:pageRange": "1263-1269", "prism:endingPage": "1269", "openaccessFlag": "false", "prism:doi": "10.3851/IMP2347", "prism:startingPage": "1263", "dc:identifier": "SCOPUS_ID:84870498215"}, "idxterms": null, "language": {"@xml:lang": "eng"}, "authkeywords": null, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Pharmacology", "@code": "3004", "@abbrev": "PHAR"}, {"@_fa": "true", "$": "Pharmacology (medical)", "@code": "2736", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Infectious Diseases", "@code": "2725", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Kulkanya", "preferred-name": {"ce:given-name": "Kulkanya", "ce:initials": "K.", "ce:surname": "Chokephaibulkit", "ce:indexed-name": "Chokephaibulkit K."}, "@seq": "1", "ce:initials": "K.", "@_fa": "true", "affiliation": {"@id": "60199575", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"}, "ce:surname": "Chokephaibulkit", "@auid": "7003974471", "author-url": "https://api.elsevier.com/content/author/author_id/7003974471", "ce:indexed-name": "Chokephaibulkit K."}, {"ce:given-name": "Wasana", "preferred-name": {"ce:given-name": "Wasana", "ce:initials": "W.", "ce:surname": "Prasitsuebsai", "ce:indexed-name": "Prasitsuebsai W."}, "@seq": "2", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, "ce:surname": "Prasitsuebsai", "@auid": "55416839500", "author-url": "https://api.elsevier.com/content/author/author_id/55416839500", "ce:indexed-name": "Prasitsuebsai W."}, {"ce:given-name": "Orasri", "preferred-name": {"ce:given-name": "Orasri", "ce:initials": "O.", "ce:surname": "Wittawatmongkol", "ce:indexed-name": "Wittawatmongkol O."}, "@seq": "3", "ce:initials": "O.", "@_fa": "true", "affiliation": {"@id": "60199575", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"}, "ce:surname": "Wittawatmongkol", "@auid": "35756672200", "author-url": "https://api.elsevier.com/content/author/author_id/35756672200", "ce:indexed-name": "Wittawatmongkol O."}, {"ce:given-name": "Meena", "preferred-name": {"ce:given-name": "Meena", "ce:initials": "M.", "ce:surname": "Gorowara", "ce:indexed-name": "Gorowara M."}, "@seq": "4", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, "ce:surname": "Gorowara", "@auid": "24472697100", "author-url": "https://api.elsevier.com/content/author/author_id/24472697100", "ce:indexed-name": "Gorowara M."}, {"ce:given-name": "Wanatpreeya", "preferred-name": {"ce:given-name": "Wanatpreeya", "ce:initials": "W.", "ce:surname": "Phongsamart", "ce:indexed-name": "Phongsamart W."}, "@seq": "5", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60199575", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"}, "ce:surname": "Phongsamart", "@auid": "8885235300", "author-url": "https://api.elsevier.com/content/author/author_id/8885235300", "ce:indexed-name": "Phongsamart W."}, {"ce:given-name": "Jiratchiya", "preferred-name": {"ce:given-name": "Jiratchiya", "ce:initials": "J.", "ce:surname": "Sophonphan", "ce:indexed-name": "Sophonphan J."}, "@seq": "6", "ce:initials": "J.", "@_fa": "true", "affiliation": {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, "ce:surname": "Sophonphan", "@auid": "55199829700", "author-url": "https://api.elsevier.com/content/author/author_id/55199829700", "ce:indexed-name": "Sophonphan J."}, {"ce:given-name": "Stephen J.", "preferred-name": {"ce:given-name": "Stephen J.", "ce:initials": "S.J.", "ce:surname": "Kerr", "ce:indexed-name": "Kerr S.J."}, "@seq": "7", "ce:initials": "S.J.", "@_fa": "true", "affiliation": [{"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, {"@id": "60026655", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655"}], "ce:surname": "Kerr", "@auid": "7102711578", "author-url": "https://api.elsevier.com/content/author/author_id/7102711578", "ce:indexed-name": "Kerr S.J."}, {"ce:given-name": "Nirun", "preferred-name": {"ce:given-name": "Nirun", "ce:initials": "N.", "ce:surname": "Vanprapar", "ce:indexed-name": "Vanprapar N."}, "@seq": "8", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60199575", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"}, "ce:surname": "Vanprapar", "@auid": "6701697019", "author-url": "https://api.elsevier.com/content/author/author_id/6701697019", "ce:indexed-name": "Vanprapar N."}, {"ce:given-name": "Thanyawee", "preferred-name": {"ce:given-name": "Thanyawee", "ce:initials": "T.", "ce:surname": "Puthanakit", "ce:indexed-name": "Puthanakit T."}, "@seq": "9", "ce:initials": "T.", "@_fa": "true", "affiliation": [{"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}], "ce:surname": "Puthanakit", "@auid": "8071686900", "author-url": "https://api.elsevier.com/content/author/author_id/8071686900", "ce:indexed-name": "Puthanakit T."}, {"ce:given-name": "Chayapa", "preferred-name": {"ce:given-name": "Chayapa", "ce:initials": "C.", "ce:surname": "Pasomsap", "ce:indexed-name": "Pasomsap C."}, "@seq": "10", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, "ce:surname": "Pasomsap", "@auid": "55510679700", "author-url": "https://api.elsevier.com/content/author/author_id/55510679700", "ce:indexed-name": "Pasomsap C."}, {"ce:given-name": "Tulathip", "preferred-name": {"ce:given-name": "Tulathip", "ce:initials": "T.", "ce:surname": "Suwanlerk", "ce:indexed-name": "Suwanlerk T."}, "@seq": "11", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, "ce:surname": "Suwanlerk", "@auid": "35304321800", "author-url": "https://api.elsevier.com/content/author/author_id/35304321800", "ce:indexed-name": "Suwanlerk T."}, {"ce:given-name": "Vanitha", "preferred-name": {"ce:given-name": "Vanitha", "ce:initials": "V.", "ce:surname": "Sekar", "ce:indexed-name": "Sekar V."}, "@seq": "12", "ce:initials": "V.", "@_fa": "true", "affiliation": {"@id": "108302187", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/108302187"}, "ce:surname": "Sekar", "@auid": "16029492500", "author-url": "https://api.elsevier.com/content/author/author_id/16029492500", "ce:indexed-name": "Sekar V."}, {"ce:given-name": "David", "preferred-name": {"ce:given-name": "David", "ce:initials": "D.", "ce:surname": "Burger", "ce:indexed-name": "Burger D."}, "@seq": "13", "ce:initials": "D.", "@_fa": "true", "affiliation": {"@id": "60002573", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002573"}, "ce:surname": "Burger", "@auid": "55540576000", "author-url": "https://api.elsevier.com/content/author/author_id/55540576000", "ce:indexed-name": "Burger D."}, {"ce:given-name": "Jintanat", "preferred-name": {"ce:given-name": "Jintanat", "ce:initials": "J.", "ce:surname": "Ananworanich", "ce:indexed-name": "Ananworanich J."}, "@seq": "14", "ce:initials": "J.", "@_fa": "true", "affiliation": [{"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, {"@id": "60026655", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655"}, {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}], "ce:surname": "Ananworanich", "@auid": "35228696200", "author-url": "https://api.elsevier.com/content/author/author_id/35228696200", "ce:indexed-name": "Ananworanich J."}]}}}